Literature DB >> 24468935

Reply: Gout treatment--more tablets might be needed.

Fernando Perez-Ruiz1, Ana Maria Herrero-Beites2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24468935     DOI： 10.1038/nrrheum.2013.173-c2

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  13 in total

1.  Crystal arthritis: Environment and genetics in gout: a maze for clinicians?

Authors:  Fernando Perez-Ruiz; Ana María Herrero-Beites
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

Review 2.  Canakinumab for gout: a specific, patient-profiled indication.

Authors:  Fernando Perez-Ruiz; Sandra P Chinchilla; Ana María Herrero-Beites
Journal:  Expert Rev Clin Immunol       Date:  2014-01-22       Impact factor: 4.473

3.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  An audit of the variability of diagnosis and management of gout in the rheumatology setting: the gout evaluation and management study.

Authors:  Fernando Perez-Ruiz; Loreto Carmona; Maria Jesús García Yébenes; Eliseo Pascual; Eugenio de Miguel; Inmaculada Ureña; Miguel A González-Gay
Journal:  J Clin Rheumatol       Date:  2011-10       Impact factor: 3.517

5.  Gout treatment: when a tablet is not enough.

Authors:  Bonifacio Alvarez-Lario; José L Alonso-Valdivielso
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

6.  Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study.

Authors:  P H Dessein; E A Shipton; A E Stanwix; B I Joffe; J Ramokgadi
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

7.  The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial.

Authors:  Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2010-08-30       Impact factor: 7.580

8.  Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.

Authors:  Frances Rees; Wendy Jenkins; M Doherty
Journal:  Ann Rheum Dis       Date:  2012-06-07       Impact factor: 19.103

9.  Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout.

Authors:  Fernando Perez-Ruiz; Lorea Martínez-Indart; Loreto Carmona; Ana Maria Herrero-Beites; Jose Ignacio Pijoan; Eswar Krishnan
Journal:  Ann Rheum Dis       Date:  2013-01-12       Impact factor: 19.103

10.  Achieving treat to target in gout: a clinical practice improvement project.

Authors:  A Y N Lim; L Shen; C H Tan; A Lateef; T C Lau; G G Teng
Journal:  Scand J Rheumatol       Date:  2012-07-28       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.